Daniel A. Peisert
2019 - DepoMed
In 2019, Daniel A. Peisert earned a total compensation of $1.6M as Senior Vice President and Chief Financial Officer at DepoMed, a 68% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $213,241 |
---|---|
Salary | $406,667 |
Stock Awards | $925,291 |
Other | $63,890 |
Total | $1,609,089 |
Peisert received $925.3K in stock awards, accounting for 58% of the total pay in 2019.
Peisert also received $213.2K in non-equity incentive plan, $406.7K in salary and $63.9K in other compensation.
Rankings
In 2019, Daniel A. Peisert's compensation ranked 6,990th out of 13,971 executives tracked by ExecPay. In other words, Peisert earned more than 50.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,990 | 50th |
Manufacturing | 2,675 | 53rd |
Chemicals And Allied Products | 980 | 55th |
Drugs | 829 | 56th |
Pharmaceutical Preparations | 609 | 56th |
Peisert's colleagues
We found two more compensation records of executives who worked with Daniel A. Peisert at DepoMed in 2019.
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019